Finerenone and Renal Oxidative Stress

NCT06244758 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Type2diabetes

Interventions

DRUG: Finerenone 20 MG Oral Tablet
DRUG: Placebo

Sponsor

University of Erlangen-Nürnberg Medical School

Collaborators

[object Object]